These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7708526)

  • 1. A new approach to managing chemotherapy-related anemia: nursing implications of epoetin alfa.
    Rieger PT; Haeuber D
    Oncol Nurs Forum; 1995; 22(1):71-81. PubMed ID: 7708526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
    Voravud N; Sriuranpong V; Suwanrusme H
    J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of epoetin alfa in chemotherapy-associated anemia.
    Jilani SM; Glaspy JA
    Semin Oncol; 1998 Oct; 25(5):571-6. PubMed ID: 9783596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
    Voravud N; Sriuranpong V
    J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meeting new challenges in the management of anemia of chronic kidney disease through collaborative care with pharmacists.
    Bacchus S; O'Mara N; Manley H; Fishbane S
    Ann Pharmacother; 2009 Nov; 43(11):1857-66. PubMed ID: 19826095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of epoetin alfa on quality of life during cancer chemotherapy: a fresh look at an old problem.
    Glaspy J
    Semin Hematol; 1997 Jul; 34(3 Suppl 2):20-6. PubMed ID: 9253780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of epoetin alfa in anemic breast cancer patients receiving chemotherapy.
    Demetri GD; Gabrilove JL; Blasi MV; Hill RJ; Glaspy J
    Clin Breast Cancer; 2002 Apr; 3(1):45-51. PubMed ID: 12020395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Updating 1999 of Standards, Options and Recommendations (SOR) for the clinical use of erythropoietin in oncology. FEDERATION OF THE FRENCH CANCER CENTRES (FNCLCC)].
    Spaëth D; Marchal C; Bataillard A; Blanc-Vincent MP
    Bull Cancer; 1999; 86(7-8):631-9. PubMed ID: 10477381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prior red blood cell transfusions in cancer patients increase the risk of subsequent transfusions with or without recombinant human erythropoietin management.
    Couture F; Turner AR; Melosky B; Xiu L; Plante RK; Lau CY; Quirt I
    Oncologist; 2005 Jan; 10(1):63-71. PubMed ID: 15632253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with epoetin alfa in the management of hemoglobin levels in orthopedic surgery and cancer. Implications for use in gynecologic surgery.
    Stovall TG
    J Reprod Med; 2001 May; 46(5 Suppl):531-8. PubMed ID: 11396387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
    Biesma B; van de Werf PR; Melissant CF; Brok RG
    Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is epoetin alfa a treatment option for chemotherapy-related anemia in children?
    Büyükpamukçu M; Varan A; Kutluk T; Akyüz C
    Med Pediatr Oncol; 2002 Oct; 39(4):455-8. PubMed ID: 12203663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cancer-related anemia with epoetin alfa: a review.
    Ferrario E; Ferrari L; Bidoli P; De Candis D; Del Vecchio M; De Dosso S; Buzzoni R; Bajetta E
    Cancer Treat Rev; 2004 Oct; 30(6):563-75. PubMed ID: 15325036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilisation review of epoetin alfa in cancer patients at a cancer centre in Singapore.
    Chan A; Lim LL; Tao M
    Singapore Med J; 2009 Apr; 50(4):365-70. PubMed ID: 19421679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies.
    Straus DJ; Testa MA; Sarokhan BJ; Czuczman MS; Tulpule A; Turner RR; Riggs SA
    Cancer; 2006 Oct; 107(8):1909-17. PubMed ID: 16977654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
    Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
    Oncologist; 2006 Feb; 11(2):197-205. PubMed ID: 16476840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-related anemia: clinical review and management update.
    Hurter B; Bush NJ
    Clin J Oncol Nurs; 2007 Jun; 11(3):349-59. PubMed ID: 17623620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of epoetin in the management of anaemia in patients with lung cancer.
    Morère JF
    Lung Cancer; 2004 Nov; 46(2):149-56. PubMed ID: 15474662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epoetin alfa and high-dose chemotherapy.
    Henry DH
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):54-7. PubMed ID: 9671332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anemia management protocols and epoetin alfa administration: an algorithm approach. Case study of the anemic patient.
    Aiello J
    Nephrol Nurs J; 2002 Jun; 29(3):297-300. PubMed ID: 12164081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.